Healthcare
UCB and Cradle partner on AI-driven protein design
UCB will apply Cradle’s AI protein-design platform to selected discovery programs spanning hit generation, lead optimization and preclinical preparation.
UCB and Cradle announced a strategic collaboration under which UCB will use Cradle’s AI-driven protein-design and engineering platform in selected discovery projects. The platform is intended to support work from hit generation through lead optimization and preclinical readiness. The collaboration applies machine learning to biologics research rather than directly to patient care. It targets an earlier stage of the healthcare value chain, where identifying and improving candidate proteins can influence the speed and quality of drug discovery. The development matters because AI-based protein engineering is being used to narrow experimental cycles and help researchers explore candidate designs more systematically. The source describes the collaboration as covering selected projects and does not disclose specific drug candidates, clinical programs, financial terms or guaranteed development outcomes.
Original source: Bio-IT World